BullFrog AI Holdings Inc Unit (BFRG)

NASDAQ
Currency in USD
1.880
+0.040(+2.17%)
Real-time Data·
BFRG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BFRG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.7701.915
52 wk Range
1.2274.840
Key Statistics
Edit
Prev. Close
1.84
Open
1.81
Day's Range
1.77-1.915
52 wk Range
1.227-4.84
Volume
39.77K
Average Volume (3m)
461.43K
1-Year Change
-40.07%
Book Value / Share
0.34
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BFRG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

BullFrog AI Holdings Inc Unit Company Profile

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.

Compare BFRG to Peers and Sector

Metrics to compare
BFRG
Peers
Sector
Relationship
P/E Ratio
−2.5x−0.7x−0.5x
PEG Ratio
−0.270.000.00
Price/Book
5.4x0.7x2.6x
Price / LTM Sales
-1.8x3.0x
Upside (Analyst Target)
-30.1%48.7%
Fair Value Upside
Unlock31.9%9.2%Unlock

Earnings

Latest Release
Mar 14, 2025
EPS / Forecast
-0.19 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the BullFrog AI Holdings Unt (BFRG) Stock Price Today?

The BullFrog AI Holdings Unt stock price today is 1.88

What Stock Exchange Does BullFrog AI Holdings Unt Trade On?

BullFrog AI Holdings Unt is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for BullFrog AI Holdings Unt?

The stock symbol for BullFrog AI Holdings Unt is "BFRG."

What Is the BullFrog AI Holdings Unt Market Cap?

As of today, BullFrog AI Holdings Unt market cap is 17.32M.

What Is BullFrog AI Holdings Unt's Earnings Per Share (TTM)?

The BullFrog AI Holdings Unt EPS (TTM) is -0.81.

From a Technical Analysis Perspective, Is BFRG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has BullFrog AI Holdings Unt Stock Split?

BullFrog AI Holdings Unt has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.